New Delhi [India], December 18: Keeping in mind the holistic health needs of women and today's evolving lifestyles, Krishna Ayurveda's specialized product "She Care Juice" has now officially entered the clinical study phase. Developed using traditional Ayurvedic herbs, this formulation has b
Tampa (Florida) [US], April 20: Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch - Sirolimus drug coated balloon (DCB), for the management of in-stent restenosis (I
Tampa (Florida) [US], April 2: Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fistula in
According to a phase II clinical study, psilocybin, a hallucinogenic chemical found in several mushrooms of the genus Psilocybe, may help persons suffering from cancer and severe depression.
Jakarta [Indonesia], November 6: As part of World Diabetes Day 2023, P&G Health, brought together renowned health experts at the '#KNOWTHESIGNS Scientific Forum'. The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN
In a new worldwide clinical study, a medication candidate based on pioneering UCL and Moorfields Eye Hospital research and presently under development by SIFI S.p.A. was found to be highly successful in treating a rare sight-threatening eye infection.
New Delhi [India], August 31: In an effort to reduce complications and average HbA1c levels for people with diabetes, BeatO, a comprehensive digital platform for controlling and managing diabetes studied the impact of its proprietary Diabetes Care Program. This program has been subjected to
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
Following promising results from pre-clinical research and a recent clinical study on stem cell-based therapies for Type 1 diabetes patients, researchers are now focusing on maximising the function and potential of stem cell-based treatments for future patient application.
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t
Tampa (Florida) [US], May 29: The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval
In a tweet, Neuralink expressed its excitement, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first